Fortress Biotech experienced a surge of approximately 10% in premarket trading on October 10, 2023, following the approval of its copper replacement therapy, Zycubo (CUTX-101), by...
The Danish drugmaker Novo Nordisk has officially launched its weight loss pill, Wegovy, in the United States as of March 15, 2024. The medication, which is...
Rocket Pharmaceuticals has voluntarily withdrawn its biologics marketing application for RP-L102, also known as mozafancogene autotemcel, from the U.S. Food and Drug Administration (FDA). This investigational...
Families across Canada are expressing both hope and frustration as two promising drugs aimed at slowing the progression of Alzheimer’s disease remain unavailable in the country....
